245 related articles for article (PubMed ID: 9681955)
1. Differential effects of neurotensin on dopamine release in the caudal and rostral nucleus accumbens: a combined in vivo electrochemical and electrophysiological study.
Sotty F; Soulière F; Brun P; Chouvet G; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
Neuroscience; 1998 Aug; 85(4):1173-82. PubMed ID: 9681955
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr(11)]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens.
Sotty F; Brun P; Leonetti M; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
Neuroscience; 2000; 98(3):485-92. PubMed ID: 10869842
[TBL] [Abstract][Full Text] [Related]
3. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area.
Suaud-Chagny MF; Chergui K; Chouvet G; Gonon F
Neuroscience; 1992 Jul; 49(1):63-72. PubMed ID: 1357587
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin receptor 1-biased ligand attenuates neurotensin-mediated excitation of ventral tegmental area dopamine neurons and dopamine release in the nucleus accumbens.
Singhal SM; Zell V; Faget L; Slosky LM; Barak LS; Caron MG; Pinkerton AB; Hnasko TS
Neuropharmacology; 2023 Aug; 234():109544. PubMed ID: 37055008
[TBL] [Abstract][Full Text] [Related]
5. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
6. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
Melis MR; Melis T; Cocco C; Succu S; Sanna F; Pillolla G; Boi A; Ferri GL; Argiolas A
Eur J Neurosci; 2007 Aug; 26(4):1026-35. PubMed ID: 17672853
[TBL] [Abstract][Full Text] [Related]
7. Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis.
Blaha CD; Coury A; Fibiger HC; Phillips AG
Neuroscience; 1990; 34(3):699-705. PubMed ID: 2352647
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo.
Rivest R; Jolicoeur FB; Marsden CA
Neuropharmacology; 1991 Jan; 30(1):25-33. PubMed ID: 2046877
[TBL] [Abstract][Full Text] [Related]
9. Continuous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry.
Dugast C; Suaud-Chagny MF; Gonon F
Neuroscience; 1994 Oct; 62(3):647-54. PubMed ID: 7870296
[TBL] [Abstract][Full Text] [Related]
10. Basolateral amygdala stimulation evokes glutamate receptor-dependent dopamine efflux in the nucleus accumbens of the anaesthetized rat.
Floresco SB; Yang CR; Phillips AG; Blaha CD
Eur J Neurosci; 1998 Apr; 10(4):1241-51. PubMed ID: 9749778
[TBL] [Abstract][Full Text] [Related]
11. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo.
Fu Y; Matta SG; Gao W; Sharp BM
Neuroscience; 2000; 101(2):369-75. PubMed ID: 11074160
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical and behavioural effects of neurotensin vs [D-Tyr11]neurotensin on mesolimbic dopaminergic function.
Steinberg R; Brun P; Souilhac J; Bougault I; Leyris R; Le Fur G; Soubrié P
Neuropeptides; 1995 Jan; 28(1):43-50. PubMed ID: 7746351
[TBL] [Abstract][Full Text] [Related]
13. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation.
You ZB; Chen YQ; Wise RA
Neuroscience; 2001; 107(4):629-39. PubMed ID: 11720786
[TBL] [Abstract][Full Text] [Related]
14. Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens.
Tanganelli S; O'Connor WT; Ferraro L; Bianchi C; Beani L; Ungerstedt U; Fuxe K
Neuroscience; 1994 Jun; 60(3):649-57. PubMed ID: 7936192
[TBL] [Abstract][Full Text] [Related]
15. Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity.
Mathé JM; Nomikos GG; Blakeman KH; Svensson TH
Neuropharmacology; 1999 Jan; 38(1):121-8. PubMed ID: 10193903
[TBL] [Abstract][Full Text] [Related]
16. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
[TBL] [Abstract][Full Text] [Related]
17. Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens.
Marinelli S; Pascucci T; Bernardi G; Puglisi-Allegra S; Mercuri NB
Neuropsychopharmacology; 2005 May; 30(5):864-70. PubMed ID: 15562294
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens.
Laitinen K; Crawley JN; Mefford IN; De Witte P
Brain Res; 1990 Jul; 523(2):342-6. PubMed ID: 1698106
[TBL] [Abstract][Full Text] [Related]
19. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study.
Yan QS; Yan SE
Eur J Pharmacol; 2001 Apr; 418(1-2):55-64. PubMed ID: 11334865
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons.
Floresco SB; Todd CL; Grace AA
J Neurosci; 2001 Jul; 21(13):4915-22. PubMed ID: 11425919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
